News
Sign up for updates
Please click the button below and fill out the form to sign up to updates from our newsletter.
Sign upCycle launches COVID-19 Response Program
Given the unprecedented COVID-19 lockdown that shuts down patient access to wellbeing facilities that may seriously…
Tyrosinemia Connections: A Live Community Event
We are extremely excited to present to you a new monthly educational online community meeting series titled…
Cycle Pharmaceuticals’ Nityr® Supply Chain Update
At Cycle Pharmaceuticals, the health and safety of patients with Hereditary Tyrosinemia Type 1 (HT-1) is our top…